Global Propofol and Ciprofol Injections Market Growth 2026-2032
The global Propofol and Ciprofol Injections market size is predicted to grow from US$ 1458 million in 2025 to US$ 1991 million in 2032; it is expected to grow at a CAGR of 4.6% from 2026 to 2032.
Propofol and ciprofol injections are intravenous short-acting sedative?hypnotic anesthetics used for general anesthesia and procedural sedation. Propofol is supplied as a white oil-in-water injectable emulsion because the drug is poorly water-soluble.
Upstream, the supply chain combines API synthesis and parenteral lipid-emulsion manufacturing with pharmaceutical excipients (e.g., soybean oil, egg lecithin/phospholipids, glycerol. Downstream, these injections are primarily used in hospitals and ambulatory procedure settings (operating rooms/anesthesia departments, endoscopy units, and in some regions ICU sedation), with strict requirements on aseptic handling and single-patient use because lipid emulsions can support microbial growth and are labeled accordingly (including allergy considerations related to egg/soy components in some products).
In 2025, global sales of propofol and ciprofol injections reached approximately 392 million units, with an average global market price of around US$ 3.8/unit. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 50% to 70%.
Propofol and ciprofol injections are short-acting IV sedative?hypnotics used across anesthesia induction/maintenance, procedural sedation (such as endoscopy), and parts of ICU sedation practice. As ambulatory surgery and outpatient procedures expand and anesthesia becomes more titration-driven, healthcare providers increasingly value agents with rapid onset, fast recovery, and controllable depth of sedation?while also paying close attention to hemodynamic fluctuation, respiratory depression, and the patient experience of injection pain, leaving room for product differentiation and formulation optimization.
On the supply side, competition is shaped not only by the API but by the quality system behind lipid-emulsion injectables: choices in the oil phase and emulsifiers (e.g., soybean oil and egg phospholipids) and the microbial-growth control strategy can influence emulsion stability, contamination risk management, and ease of clinical use. Labels for propofol emulsions commonly emphasize strict aseptic handling, single-patient use, and allergy considerations tied to egg/soy components, so reliable supply, batch-to-batch consistency, and documentation/compliance capability often determine access to top-tier hospitals and high-throughput endoscopy chains.
Looking ahead, propofol is highly genericized in many markets, making procurement and cost efficiency central. In parallel, ?improved? molecules positioned for potentially smoother hemodynamics and lower injection pain?such as ciprofol in regions where it is approved?are being adopted more rapidly, creating a two-layer structure of high-volume generics plus next-generation alternatives. Building defensible advantage typically requires a combination of clinical evidence, control over critical excipients, robust aseptic fill?finish capabilities, and deep linkage to high-frequency clinical scenarios like anesthesia and GI endoscopy.
LP Information, Inc. (LPI) ' newest research report, the ?Propofol and Ciprofol Injections Industry Forecast? looks at past sales and reviews total world Propofol and Ciprofol Injections sales in 2025, providing a comprehensive analysis by region and market sector of projected Propofol and Ciprofol Injections sales for 2026 through 2032. With Propofol and Ciprofol Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Propofol and Ciprofol Injections industry.
This Insight Report provides a comprehensive analysis of the global Propofol and Ciprofol Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Propofol and Ciprofol Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Propofol and Ciprofol Injections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Propofol and Ciprofol Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Propofol and Ciprofol Injections.
This report presents a comprehensive overview, market shares, and growth opportunities of Propofol and Ciprofol Injections market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Propofol and ciprofol injections are intravenous short-acting sedative?hypnotic anesthetics used for general anesthesia and procedural sedation. Propofol is supplied as a white oil-in-water injectable emulsion because the drug is poorly water-soluble.
Upstream, the supply chain combines API synthesis and parenteral lipid-emulsion manufacturing with pharmaceutical excipients (e.g., soybean oil, egg lecithin/phospholipids, glycerol. Downstream, these injections are primarily used in hospitals and ambulatory procedure settings (operating rooms/anesthesia departments, endoscopy units, and in some regions ICU sedation), with strict requirements on aseptic handling and single-patient use because lipid emulsions can support microbial growth and are labeled accordingly (including allergy considerations related to egg/soy components in some products).
In 2025, global sales of propofol and ciprofol injections reached approximately 392 million units, with an average global market price of around US$ 3.8/unit. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 50% to 70%.
Propofol and ciprofol injections are short-acting IV sedative?hypnotics used across anesthesia induction/maintenance, procedural sedation (such as endoscopy), and parts of ICU sedation practice. As ambulatory surgery and outpatient procedures expand and anesthesia becomes more titration-driven, healthcare providers increasingly value agents with rapid onset, fast recovery, and controllable depth of sedation?while also paying close attention to hemodynamic fluctuation, respiratory depression, and the patient experience of injection pain, leaving room for product differentiation and formulation optimization.
On the supply side, competition is shaped not only by the API but by the quality system behind lipid-emulsion injectables: choices in the oil phase and emulsifiers (e.g., soybean oil and egg phospholipids) and the microbial-growth control strategy can influence emulsion stability, contamination risk management, and ease of clinical use. Labels for propofol emulsions commonly emphasize strict aseptic handling, single-patient use, and allergy considerations tied to egg/soy components, so reliable supply, batch-to-batch consistency, and documentation/compliance capability often determine access to top-tier hospitals and high-throughput endoscopy chains.
Looking ahead, propofol is highly genericized in many markets, making procurement and cost efficiency central. In parallel, ?improved? molecules positioned for potentially smoother hemodynamics and lower injection pain?such as ciprofol in regions where it is approved?are being adopted more rapidly, creating a two-layer structure of high-volume generics plus next-generation alternatives. Building defensible advantage typically requires a combination of clinical evidence, control over critical excipients, robust aseptic fill?finish capabilities, and deep linkage to high-frequency clinical scenarios like anesthesia and GI endoscopy.
LP Information, Inc. (LPI) ' newest research report, the ?Propofol and Ciprofol Injections Industry Forecast? looks at past sales and reviews total world Propofol and Ciprofol Injections sales in 2025, providing a comprehensive analysis by region and market sector of projected Propofol and Ciprofol Injections sales for 2026 through 2032. With Propofol and Ciprofol Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Propofol and Ciprofol Injections industry.
This Insight Report provides a comprehensive analysis of the global Propofol and Ciprofol Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Propofol and Ciprofol Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Propofol and Ciprofol Injections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Propofol and Ciprofol Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Propofol and Ciprofol Injections.
This report presents a comprehensive overview, market shares, and growth opportunities of Propofol and Ciprofol Injections market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Propofol Injections
- Ciprofol Injections
- 1%
- 2%
- Other
- 10 mL
- 20 mL
- 50 mL
- 100 mL
- General Anesthesia
- Medical Procedures Sedation
- Mechanical Ventilation
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Fresenius Kabi
- Pfizer
- B. Braun
- Sagent Pharmaceuticals
- Dr. Reddy's Laboratories
- Rusoma
- Centurion Healthcare
- Wellona Pharma
- Hikma Pharmaceuticals
- Avet Pharmaceuticals
- Xi?an Libang Pharmaceutical
- Guangdong Jiabo Pharmaceutical
- Sichuan Biokin Pharmaceutical
- Sichuan Kelun Pharmaceutical
- Jiangsu Nhwa Pharmaceutical
- Jiangsu Yingke Biopharmaceutical
- Haisco Pharmaceutical Group
- What is the 10-year outlook for the global Propofol and Ciprofol Injections market?
- What factors are driving Propofol and Ciprofol Injections market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Propofol and Ciprofol Injections market opportunities vary by end market size?
- How does Propofol and Ciprofol Injections break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Propofol and Ciprofol Injections Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Propofol and Ciprofol Injections by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Propofol and Ciprofol Injections by Country/Region, 2021, 2025 & 2032
2.2 Propofol and Ciprofol Injections Segment by Type
2.2.1 Propofol Injections
2.2.2 Ciprofol Injections
2.2.3 Propofol and Ciprofol Injections Sales by Type
2.2.3.1 Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
2.2.3.2 Global Propofol and Ciprofol Injections Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Propofol and Ciprofol Injections Sale Price by Type (2021-2026)
2.3 Propofol and Ciprofol Injections Segment by Concentration
2.3.1 1%
2.3.2 2%
2.3.3 Other
2.3.4 Propofol and Ciprofol Injections Sales by Concentration
2.3.4.1 Global Propofol and Ciprofol Injections Sales Market Share by Concentration (2021-2026)
2.3.4.2 Global Propofol and Ciprofol Injections Revenue and Market Share by Concentration (2021-2026)
2.3.4.3 Global Propofol and Ciprofol Injections Sale Price by Concentration (2021-2026)
2.4 Propofol and Ciprofol Injections Segment by Packaging
2.4.1 10 mL
2.4.2 20 mL
2.4.3 50 mL
2.4.4 100 mL
2.4.5 Propofol and Ciprofol Injections Sales by Packaging
2.4.5.1 Global Propofol and Ciprofol Injections Sales Market Share by Packaging (2021-2026)
2.4.5.2 Global Propofol and Ciprofol Injections Revenue and Market Share by Packaging (2021-2026)
2.4.5.3 Global Propofol and Ciprofol Injections Sale Price by Packaging (2021-2026)
2.5 Propofol and Ciprofol Injections Segment by Application
2.5.1 General Anesthesia
2.5.2 Medical Procedures Sedation
2.5.3 Mechanical Ventilation
2.5.4 Other
2.5.5 Propofol and Ciprofol Injections Sales by Application
2.5.5.1 Global Propofol and Ciprofol Injections Sale Market Share by Application (2021-2026)
2.5.5.2 Global Propofol and Ciprofol Injections Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Propofol and Ciprofol Injections Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Propofol and Ciprofol Injections Breakdown Data by Company
3.1.1 Global Propofol and Ciprofol Injections Annual Sales by Company (2021-2026)
3.1.2 Global Propofol and Ciprofol Injections Sales Market Share by Company (2021-2026)
3.2 Global Propofol and Ciprofol Injections Annual Revenue by Company (2021-2026)
3.2.1 Global Propofol and Ciprofol Injections Revenue by Company (2021-2026)
3.2.2 Global Propofol and Ciprofol Injections Revenue Market Share by Company (2021-2026)
3.3 Global Propofol and Ciprofol Injections Sale Price by Company
3.4 Key Manufacturers Propofol and Ciprofol Injections Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Propofol and Ciprofol Injections Product Location Distribution
3.4.2 Players Propofol and Ciprofol Injections Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROPOFOL AND CIPROFOL INJECTIONS BY GEOGRAPHIC REGION
4.1 World Historic Propofol and Ciprofol Injections Market Size by Geographic Region (2021-2026)
4.1.1 Global Propofol and Ciprofol Injections Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Propofol and Ciprofol Injections Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Propofol and Ciprofol Injections Market Size by Country/Region (2021-2026)
4.2.1 Global Propofol and Ciprofol Injections Annual Sales by Country/Region (2021-2026)
4.2.2 Global Propofol and Ciprofol Injections Annual Revenue by Country/Region (2021-2026)
4.3 Americas Propofol and Ciprofol Injections Sales Growth
4.4 APAC Propofol and Ciprofol Injections Sales Growth
4.5 Europe Propofol and Ciprofol Injections Sales Growth
4.6 Middle East & Africa Propofol and Ciprofol Injections Sales Growth
5 AMERICAS
5.1 Americas Propofol and Ciprofol Injections Sales by Country
5.1.1 Americas Propofol and Ciprofol Injections Sales by Country (2021-2026)
5.1.2 Americas Propofol and Ciprofol Injections Revenue by Country (2021-2026)
5.2 Americas Propofol and Ciprofol Injections Sales by Type (2021-2026)
5.3 Americas Propofol and Ciprofol Injections Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Propofol and Ciprofol Injections Sales by Region
6.1.1 APAC Propofol and Ciprofol Injections Sales by Region (2021-2026)
6.1.2 APAC Propofol and Ciprofol Injections Revenue by Region (2021-2026)
6.2 APAC Propofol and Ciprofol Injections Sales by Type (2021-2026)
6.3 APAC Propofol and Ciprofol Injections Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Propofol and Ciprofol Injections by Country
7.1.1 Europe Propofol and Ciprofol Injections Sales by Country (2021-2026)
7.1.2 Europe Propofol and Ciprofol Injections Revenue by Country (2021-2026)
7.2 Europe Propofol and Ciprofol Injections Sales by Type (2021-2026)
7.3 Europe Propofol and Ciprofol Injections Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Propofol and Ciprofol Injections by Country
8.1.1 Middle East & Africa Propofol and Ciprofol Injections Sales by Country (2021-2026)
8.1.2 Middle East & Africa Propofol and Ciprofol Injections Revenue by Country (2021-2026)
8.2 Middle East & Africa Propofol and Ciprofol Injections Sales by Type (2021-2026)
8.3 Middle East & Africa Propofol and Ciprofol Injections Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Propofol and Ciprofol Injections
10.3 Manufacturing Process Analysis of Propofol and Ciprofol Injections
10.4 Industry Chain Structure of Propofol and Ciprofol Injections
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Propofol and Ciprofol Injections Distributors
11.3 Propofol and Ciprofol Injections Customer
12 WORLD FORECAST REVIEW FOR PROPOFOL AND CIPROFOL INJECTIONS BY GEOGRAPHIC REGION
12.1 Global Propofol and Ciprofol Injections Market Size Forecast by Region
12.1.1 Global Propofol and Ciprofol Injections Forecast by Region (2027-2032)
12.1.2 Global Propofol and Ciprofol Injections Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Propofol and Ciprofol Injections Forecast by Type (2027-2032)
12.7 Global Propofol and Ciprofol Injections Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Fresenius Kabi
13.1.1 Fresenius Kabi Company Information
13.1.2 Fresenius Kabi Propofol and Ciprofol Injections Product Portfolios and Specifications
13.1.3 Fresenius Kabi Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Fresenius Kabi Main Business Overview
13.1.5 Fresenius Kabi Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Propofol and Ciprofol Injections Product Portfolios and Specifications
13.2.3 Pfizer Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 B. Braun
13.3.1 B. Braun Company Information
13.3.2 B. Braun Propofol and Ciprofol Injections Product Portfolios and Specifications
13.3.3 B. Braun Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 B. Braun Main Business Overview
13.3.5 B. Braun Latest Developments
13.4 Sagent Pharmaceuticals
13.4.1 Sagent Pharmaceuticals Company Information
13.4.2 Sagent Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
13.4.3 Sagent Pharmaceuticals Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sagent Pharmaceuticals Main Business Overview
13.4.5 Sagent Pharmaceuticals Latest Developments
13.5 Dr. Reddy's Laboratories
13.5.1 Dr. Reddy's Laboratories Company Information
13.5.2 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolios and Specifications
13.5.3 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Dr. Reddy's Laboratories Main Business Overview
13.5.5 Dr. Reddy's Laboratories Latest Developments
13.6 Rusoma
13.6.1 Rusoma Company Information
13.6.2 Rusoma Propofol and Ciprofol Injections Product Portfolios and Specifications
13.6.3 Rusoma Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Rusoma Main Business Overview
13.6.5 Rusoma Latest Developments
13.7 Centurion Healthcare
13.7.1 Centurion Healthcare Company Information
13.7.2 Centurion Healthcare Propofol and Ciprofol Injections Product Portfolios and Specifications
13.7.3 Centurion Healthcare Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Centurion Healthcare Main Business Overview
13.7.5 Centurion Healthcare Latest Developments
13.8 Wellona Pharma
13.8.1 Wellona Pharma Company Information
13.8.2 Wellona Pharma Propofol and Ciprofol Injections Product Portfolios and Specifications
13.8.3 Wellona Pharma Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Wellona Pharma Main Business Overview
13.8.5 Wellona Pharma Latest Developments
13.9 Hikma Pharmaceuticals
13.9.1 Hikma Pharmaceuticals Company Information
13.9.2 Hikma Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
13.9.3 Hikma Pharmaceuticals Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hikma Pharmaceuticals Main Business Overview
13.9.5 Hikma Pharmaceuticals Latest Developments
13.10 Avet Pharmaceuticals
13.10.1 Avet Pharmaceuticals Company Information
13.10.2 Avet Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
13.10.3 Avet Pharmaceuticals Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Avet Pharmaceuticals Main Business Overview
13.10.5 Avet Pharmaceuticals Latest Developments
13.11 Xi?an Libang Pharmaceutical
13.11.1 Xi?an Libang Pharmaceutical Company Information
13.11.2 Xi?an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.11.3 Xi?an Libang Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Xi?an Libang Pharmaceutical Main Business Overview
13.11.5 Xi?an Libang Pharmaceutical Latest Developments
13.12 Guangdong Jiabo Pharmaceutical
13.12.1 Guangdong Jiabo Pharmaceutical Company Information
13.12.2 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.12.3 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Guangdong Jiabo Pharmaceutical Main Business Overview
13.12.5 Guangdong Jiabo Pharmaceutical Latest Developments
13.13 Sichuan Biokin Pharmaceutical
13.13.1 Sichuan Biokin Pharmaceutical Company Information
13.13.2 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.13.3 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Sichuan Biokin Pharmaceutical Main Business Overview
13.13.5 Sichuan Biokin Pharmaceutical Latest Developments
13.14 Sichuan Kelun Pharmaceutical
13.14.1 Sichuan Kelun Pharmaceutical Company Information
13.14.2 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.14.3 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sichuan Kelun Pharmaceutical Main Business Overview
13.14.5 Sichuan Kelun Pharmaceutical Latest Developments
13.15 Jiangsu Nhwa Pharmaceutical
13.15.1 Jiangsu Nhwa Pharmaceutical Company Information
13.15.2 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.15.3 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
13.15.5 Jiangsu Nhwa Pharmaceutical Latest Developments
13.16 Jiangsu Yingke Biopharmaceutical
13.16.1 Jiangsu Yingke Biopharmaceutical Company Information
13.16.2 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.16.3 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Jiangsu Yingke Biopharmaceutical Main Business Overview
13.16.5 Jiangsu Yingke Biopharmaceutical Latest Developments
13.17 Haisco Pharmaceutical Group
13.17.1 Haisco Pharmaceutical Group Company Information
13.17.2 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolios and Specifications
13.17.3 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Haisco Pharmaceutical Group Main Business Overview
13.17.5 Haisco Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Propofol and Ciprofol Injections Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Propofol and Ciprofol Injections by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Propofol and Ciprofol Injections by Country/Region, 2021, 2025 & 2032
2.2 Propofol and Ciprofol Injections Segment by Type
2.2.1 Propofol Injections
2.2.2 Ciprofol Injections
2.2.3 Propofol and Ciprofol Injections Sales by Type
2.2.3.1 Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
2.2.3.2 Global Propofol and Ciprofol Injections Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Propofol and Ciprofol Injections Sale Price by Type (2021-2026)
2.3 Propofol and Ciprofol Injections Segment by Concentration
2.3.1 1%
2.3.2 2%
2.3.3 Other
2.3.4 Propofol and Ciprofol Injections Sales by Concentration
2.3.4.1 Global Propofol and Ciprofol Injections Sales Market Share by Concentration (2021-2026)
2.3.4.2 Global Propofol and Ciprofol Injections Revenue and Market Share by Concentration (2021-2026)
2.3.4.3 Global Propofol and Ciprofol Injections Sale Price by Concentration (2021-2026)
2.4 Propofol and Ciprofol Injections Segment by Packaging
2.4.1 10 mL
2.4.2 20 mL
2.4.3 50 mL
2.4.4 100 mL
2.4.5 Propofol and Ciprofol Injections Sales by Packaging
2.4.5.1 Global Propofol and Ciprofol Injections Sales Market Share by Packaging (2021-2026)
2.4.5.2 Global Propofol and Ciprofol Injections Revenue and Market Share by Packaging (2021-2026)
2.4.5.3 Global Propofol and Ciprofol Injections Sale Price by Packaging (2021-2026)
2.5 Propofol and Ciprofol Injections Segment by Application
2.5.1 General Anesthesia
2.5.2 Medical Procedures Sedation
2.5.3 Mechanical Ventilation
2.5.4 Other
2.5.5 Propofol and Ciprofol Injections Sales by Application
2.5.5.1 Global Propofol and Ciprofol Injections Sale Market Share by Application (2021-2026)
2.5.5.2 Global Propofol and Ciprofol Injections Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Propofol and Ciprofol Injections Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Propofol and Ciprofol Injections Breakdown Data by Company
3.1.1 Global Propofol and Ciprofol Injections Annual Sales by Company (2021-2026)
3.1.2 Global Propofol and Ciprofol Injections Sales Market Share by Company (2021-2026)
3.2 Global Propofol and Ciprofol Injections Annual Revenue by Company (2021-2026)
3.2.1 Global Propofol and Ciprofol Injections Revenue by Company (2021-2026)
3.2.2 Global Propofol and Ciprofol Injections Revenue Market Share by Company (2021-2026)
3.3 Global Propofol and Ciprofol Injections Sale Price by Company
3.4 Key Manufacturers Propofol and Ciprofol Injections Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Propofol and Ciprofol Injections Product Location Distribution
3.4.2 Players Propofol and Ciprofol Injections Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROPOFOL AND CIPROFOL INJECTIONS BY GEOGRAPHIC REGION
4.1 World Historic Propofol and Ciprofol Injections Market Size by Geographic Region (2021-2026)
4.1.1 Global Propofol and Ciprofol Injections Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Propofol and Ciprofol Injections Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Propofol and Ciprofol Injections Market Size by Country/Region (2021-2026)
4.2.1 Global Propofol and Ciprofol Injections Annual Sales by Country/Region (2021-2026)
4.2.2 Global Propofol and Ciprofol Injections Annual Revenue by Country/Region (2021-2026)
4.3 Americas Propofol and Ciprofol Injections Sales Growth
4.4 APAC Propofol and Ciprofol Injections Sales Growth
4.5 Europe Propofol and Ciprofol Injections Sales Growth
4.6 Middle East & Africa Propofol and Ciprofol Injections Sales Growth
5 AMERICAS
5.1 Americas Propofol and Ciprofol Injections Sales by Country
5.1.1 Americas Propofol and Ciprofol Injections Sales by Country (2021-2026)
5.1.2 Americas Propofol and Ciprofol Injections Revenue by Country (2021-2026)
5.2 Americas Propofol and Ciprofol Injections Sales by Type (2021-2026)
5.3 Americas Propofol and Ciprofol Injections Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Propofol and Ciprofol Injections Sales by Region
6.1.1 APAC Propofol and Ciprofol Injections Sales by Region (2021-2026)
6.1.2 APAC Propofol and Ciprofol Injections Revenue by Region (2021-2026)
6.2 APAC Propofol and Ciprofol Injections Sales by Type (2021-2026)
6.3 APAC Propofol and Ciprofol Injections Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Propofol and Ciprofol Injections by Country
7.1.1 Europe Propofol and Ciprofol Injections Sales by Country (2021-2026)
7.1.2 Europe Propofol and Ciprofol Injections Revenue by Country (2021-2026)
7.2 Europe Propofol and Ciprofol Injections Sales by Type (2021-2026)
7.3 Europe Propofol and Ciprofol Injections Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Propofol and Ciprofol Injections by Country
8.1.1 Middle East & Africa Propofol and Ciprofol Injections Sales by Country (2021-2026)
8.1.2 Middle East & Africa Propofol and Ciprofol Injections Revenue by Country (2021-2026)
8.2 Middle East & Africa Propofol and Ciprofol Injections Sales by Type (2021-2026)
8.3 Middle East & Africa Propofol and Ciprofol Injections Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Propofol and Ciprofol Injections
10.3 Manufacturing Process Analysis of Propofol and Ciprofol Injections
10.4 Industry Chain Structure of Propofol and Ciprofol Injections
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Propofol and Ciprofol Injections Distributors
11.3 Propofol and Ciprofol Injections Customer
12 WORLD FORECAST REVIEW FOR PROPOFOL AND CIPROFOL INJECTIONS BY GEOGRAPHIC REGION
12.1 Global Propofol and Ciprofol Injections Market Size Forecast by Region
12.1.1 Global Propofol and Ciprofol Injections Forecast by Region (2027-2032)
12.1.2 Global Propofol and Ciprofol Injections Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Propofol and Ciprofol Injections Forecast by Type (2027-2032)
12.7 Global Propofol and Ciprofol Injections Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Fresenius Kabi
13.1.1 Fresenius Kabi Company Information
13.1.2 Fresenius Kabi Propofol and Ciprofol Injections Product Portfolios and Specifications
13.1.3 Fresenius Kabi Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Fresenius Kabi Main Business Overview
13.1.5 Fresenius Kabi Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Propofol and Ciprofol Injections Product Portfolios and Specifications
13.2.3 Pfizer Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 B. Braun
13.3.1 B. Braun Company Information
13.3.2 B. Braun Propofol and Ciprofol Injections Product Portfolios and Specifications
13.3.3 B. Braun Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 B. Braun Main Business Overview
13.3.5 B. Braun Latest Developments
13.4 Sagent Pharmaceuticals
13.4.1 Sagent Pharmaceuticals Company Information
13.4.2 Sagent Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
13.4.3 Sagent Pharmaceuticals Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sagent Pharmaceuticals Main Business Overview
13.4.5 Sagent Pharmaceuticals Latest Developments
13.5 Dr. Reddy's Laboratories
13.5.1 Dr. Reddy's Laboratories Company Information
13.5.2 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolios and Specifications
13.5.3 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Dr. Reddy's Laboratories Main Business Overview
13.5.5 Dr. Reddy's Laboratories Latest Developments
13.6 Rusoma
13.6.1 Rusoma Company Information
13.6.2 Rusoma Propofol and Ciprofol Injections Product Portfolios and Specifications
13.6.3 Rusoma Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Rusoma Main Business Overview
13.6.5 Rusoma Latest Developments
13.7 Centurion Healthcare
13.7.1 Centurion Healthcare Company Information
13.7.2 Centurion Healthcare Propofol and Ciprofol Injections Product Portfolios and Specifications
13.7.3 Centurion Healthcare Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Centurion Healthcare Main Business Overview
13.7.5 Centurion Healthcare Latest Developments
13.8 Wellona Pharma
13.8.1 Wellona Pharma Company Information
13.8.2 Wellona Pharma Propofol and Ciprofol Injections Product Portfolios and Specifications
13.8.3 Wellona Pharma Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Wellona Pharma Main Business Overview
13.8.5 Wellona Pharma Latest Developments
13.9 Hikma Pharmaceuticals
13.9.1 Hikma Pharmaceuticals Company Information
13.9.2 Hikma Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
13.9.3 Hikma Pharmaceuticals Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hikma Pharmaceuticals Main Business Overview
13.9.5 Hikma Pharmaceuticals Latest Developments
13.10 Avet Pharmaceuticals
13.10.1 Avet Pharmaceuticals Company Information
13.10.2 Avet Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
13.10.3 Avet Pharmaceuticals Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Avet Pharmaceuticals Main Business Overview
13.10.5 Avet Pharmaceuticals Latest Developments
13.11 Xi?an Libang Pharmaceutical
13.11.1 Xi?an Libang Pharmaceutical Company Information
13.11.2 Xi?an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.11.3 Xi?an Libang Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Xi?an Libang Pharmaceutical Main Business Overview
13.11.5 Xi?an Libang Pharmaceutical Latest Developments
13.12 Guangdong Jiabo Pharmaceutical
13.12.1 Guangdong Jiabo Pharmaceutical Company Information
13.12.2 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.12.3 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Guangdong Jiabo Pharmaceutical Main Business Overview
13.12.5 Guangdong Jiabo Pharmaceutical Latest Developments
13.13 Sichuan Biokin Pharmaceutical
13.13.1 Sichuan Biokin Pharmaceutical Company Information
13.13.2 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.13.3 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Sichuan Biokin Pharmaceutical Main Business Overview
13.13.5 Sichuan Biokin Pharmaceutical Latest Developments
13.14 Sichuan Kelun Pharmaceutical
13.14.1 Sichuan Kelun Pharmaceutical Company Information
13.14.2 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.14.3 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sichuan Kelun Pharmaceutical Main Business Overview
13.14.5 Sichuan Kelun Pharmaceutical Latest Developments
13.15 Jiangsu Nhwa Pharmaceutical
13.15.1 Jiangsu Nhwa Pharmaceutical Company Information
13.15.2 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.15.3 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
13.15.5 Jiangsu Nhwa Pharmaceutical Latest Developments
13.16 Jiangsu Yingke Biopharmaceutical
13.16.1 Jiangsu Yingke Biopharmaceutical Company Information
13.16.2 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.16.3 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Jiangsu Yingke Biopharmaceutical Main Business Overview
13.16.5 Jiangsu Yingke Biopharmaceutical Latest Developments
13.17 Haisco Pharmaceutical Group
13.17.1 Haisco Pharmaceutical Group Company Information
13.17.2 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolios and Specifications
13.17.3 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Haisco Pharmaceutical Group Main Business Overview
13.17.5 Haisco Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Propofol and Ciprofol Injections Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Propofol and Ciprofol Injections Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Propofol Injections
Table 4. Major Players of Ciprofol Injections
Table 5. Global Propofol and Ciprofol Injections Sales by Type (2021-2026) & (K Units)
Table 6. Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
Table 7. Global Propofol and Ciprofol Injections Revenue by Type (2021-2026) & ($ million)
Table 8. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2026)
Table 9. Global Propofol and Ciprofol Injections Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of 1%
Table 11. Major Players of 2%
Table 12. Major Players of Other
Table 13. Global Propofol and Ciprofol Injections Sales by Concentration (2021-2026) & (K Units)
Table 14. Global Propofol and Ciprofol Injections Sales Market Share by Concentration (2021-2026)
Table 15. Global Propofol and Ciprofol Injections Revenue by Concentration (2021-2026) & ($ million)
Table 16. Global Propofol and Ciprofol Injections Revenue Market Share by Concentration (2021-2026)
Table 17. Global Propofol and Ciprofol Injections Sale Price by Concentration (2021-2026) & (US$/Unit)
Table 18. Major Players of 10 mL
Table 19. Major Players of 20 mL
Table 20. Major Players of 50 mL
Table 21. Major Players of 100 mL
Table 22. Global Propofol and Ciprofol Injections Sales by Packaging (2021-2026) & (K Units)
Table 23. Global Propofol and Ciprofol Injections Sales Market Share by Packaging (2021-2026)
Table 24. Global Propofol and Ciprofol Injections Revenue by Packaging (2021-2026) & ($ million)
Table 25. Global Propofol and Ciprofol Injections Revenue Market Share by Packaging (2021-2026)
Table 26. Global Propofol and Ciprofol Injections Sale Price by Packaging (2021-2026) & (US$/Unit)
Table 27. Global Propofol and Ciprofol Injections Sale by Application (2021-2026) & (K Units)
Table 28. Global Propofol and Ciprofol Injections Sale Market Share by Application (2021-2026)
Table 29. Global Propofol and Ciprofol Injections Revenue by Application (2021-2026) & ($ million)
Table 30. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021-2026)
Table 31. Global Propofol and Ciprofol Injections Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Propofol and Ciprofol Injections Sales by Company (2021-2026) & (K Units)
Table 33. Global Propofol and Ciprofol Injections Sales Market Share by Company (2021-2026)
Table 34. Global Propofol and Ciprofol Injections Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Propofol and Ciprofol Injections Revenue Market Share by Company (2021-2026)
Table 36. Global Propofol and Ciprofol Injections Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Propofol and Ciprofol Injections Producing Area Distribution and Sales Area
Table 38. Players Propofol and Ciprofol Injections Products Offered
Table 39. Propofol and Ciprofol Injections Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Propofol and Ciprofol Injections Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Propofol and Ciprofol Injections Sales Market Share Geographic Region (2021-2026)
Table 44. Global Propofol and Ciprofol Injections Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Propofol and Ciprofol Injections Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Propofol and Ciprofol Injections Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Propofol and Ciprofol Injections Sales Market Share by Country/Region (2021-2026)
Table 48. Global Propofol and Ciprofol Injections Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Propofol and Ciprofol Injections Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Propofol and Ciprofol Injections Sales by Country (2021-2026) & (K Units)
Table 51. Americas Propofol and Ciprofol Injections Sales Market Share by Country (2021-2026)
Table 52. Americas Propofol and Ciprofol Injections Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Propofol and Ciprofol Injections Sales by Type (2021-2026) & (K Units)
Table 54. Americas Propofol and Ciprofol Injections Sales by Application (2021-2026) & (K Units)
Table 55. APAC Propofol and Ciprofol Injections Sales by Region (2021-2026) & (K Units)
Table 56. APAC Propofol and Ciprofol Injections Sales Market Share by Region (2021-2026)
Table 57. APAC Propofol and Ciprofol Injections Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Propofol and Ciprofol Injections Sales by Type (2021-2026) & (K Units)
Table 59. APAC Propofol and Ciprofol Injections Sales by Application (2021-2026) & (K Units)
Table 60. Europe Propofol and Ciprofol Injections Sales by Country (2021-2026) & (K Units)
Table 61. Europe Propofol and Ciprofol Injections Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Propofol and Ciprofol Injections Sales by Type (2021-2026) & (K Units)
Table 63. Europe Propofol and Ciprofol Injections Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Propofol and Ciprofol Injections Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Propofol and Ciprofol Injections Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Propofol and Ciprofol Injections Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Propofol and Ciprofol Injections Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Propofol and Ciprofol Injections
Table 69. Key Market Challenges & Risks of Propofol and Ciprofol Injections
Table 70. Key Industry Trends of Propofol and Ciprofol Injections
Table 71. Propofol and Ciprofol Injections Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Propofol and Ciprofol Injections Distributors List
Table 74. Propofol and Ciprofol Injections Customer List
Table 75. Global Propofol and Ciprofol Injections Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Propofol and Ciprofol Injections Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Propofol and Ciprofol Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Propofol and Ciprofol Injections Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Propofol and Ciprofol Injections Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Propofol and Ciprofol Injections Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Propofol and Ciprofol Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Propofol and Ciprofol Injections Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Propofol and Ciprofol Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Propofol and Ciprofol Injections Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Propofol and Ciprofol Injections Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Propofol and Ciprofol Injections Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Propofol and Ciprofol Injections Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Propofol and Ciprofol Injections Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Fresenius Kabi Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 90. Fresenius Kabi Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 91. Fresenius Kabi Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Fresenius Kabi Main Business
Table 93. Fresenius Kabi Latest Developments
Table 94. Pfizer Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 96. Pfizer Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. B. Braun Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 100. B. Braun Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 101. B. Braun Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. B. Braun Main Business
Table 103. B. Braun Latest Developments
Table 104. Sagent Pharmaceuticals Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 105. Sagent Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 106. Sagent Pharmaceuticals Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Sagent Pharmaceuticals Main Business
Table 108. Sagent Pharmaceuticals Latest Developments
Table 109. Dr. Reddy's Laboratories Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 110. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 111. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Dr. Reddy's Laboratories Main Business
Table 113. Dr. Reddy's Laboratories Latest Developments
Table 114. Rusoma Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 115. Rusoma Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 116. Rusoma Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Rusoma Main Business
Table 118. Rusoma Latest Developments
Table 119. Centurion Healthcare Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 120. Centurion Healthcare Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 121. Centurion Healthcare Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Centurion Healthcare Main Business
Table 123. Centurion Healthcare Latest Developments
Table 124. Wellona Pharma Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 125. Wellona Pharma Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 126. Wellona Pharma Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Wellona Pharma Main Business
Table 128. Wellona Pharma Latest Developments
Table 129. Hikma Pharmaceuticals Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 130. Hikma Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 131. Hikma Pharmaceuticals Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Hikma Pharmaceuticals Main Business
Table 133. Hikma Pharmaceuticals Latest Developments
Table 134. Avet Pharmaceuticals Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 135. Avet Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 136. Avet Pharmaceuticals Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Avet Pharmaceuticals Main Business
Table 138. Avet Pharmaceuticals Latest Developments
Table 139. Xi?an Libang Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 140. Xi?an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 141. Xi?an Libang Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Xi?an Libang Pharmaceutical Main Business
Table 143. Xi?an Libang Pharmaceutical Latest Developments
Table 144. Guangdong Jiabo Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 145. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 146. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Guangdong Jiabo Pharmaceutical Main Business
Table 148. Guangdong Jiabo Pharmaceutical Latest Developments
Table 149. Sichuan Biokin Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 150. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 151. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Sichuan Biokin Pharmaceutical Main Business
Table 153. Sichuan Biokin Pharmaceutical Latest Developments
Table 154. Sichuan Kelun Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 155. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 156. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Sichuan Kelun Pharmaceutical Main Business
Table 158. Sichuan Kelun Pharmaceutical Latest Developments
Table 159. Jiangsu Nhwa Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 160. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 161. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Jiangsu Nhwa Pharmaceutical Main Business
Table 163. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 164. Jiangsu Yingke Biopharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 165. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 166. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Jiangsu Yingke Biopharmaceutical Main Business
Table 168. Jiangsu Yingke Biopharmaceutical Latest Developments
Table 169. Haisco Pharmaceutical Group Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 170. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 171. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Haisco Pharmaceutical Group Main Business
Table 173. Haisco Pharmaceutical Group Latest Developments
Table 1. Propofol and Ciprofol Injections Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Propofol and Ciprofol Injections Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Propofol Injections
Table 4. Major Players of Ciprofol Injections
Table 5. Global Propofol and Ciprofol Injections Sales by Type (2021-2026) & (K Units)
Table 6. Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
Table 7. Global Propofol and Ciprofol Injections Revenue by Type (2021-2026) & ($ million)
Table 8. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2026)
Table 9. Global Propofol and Ciprofol Injections Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of 1%
Table 11. Major Players of 2%
Table 12. Major Players of Other
Table 13. Global Propofol and Ciprofol Injections Sales by Concentration (2021-2026) & (K Units)
Table 14. Global Propofol and Ciprofol Injections Sales Market Share by Concentration (2021-2026)
Table 15. Global Propofol and Ciprofol Injections Revenue by Concentration (2021-2026) & ($ million)
Table 16. Global Propofol and Ciprofol Injections Revenue Market Share by Concentration (2021-2026)
Table 17. Global Propofol and Ciprofol Injections Sale Price by Concentration (2021-2026) & (US$/Unit)
Table 18. Major Players of 10 mL
Table 19. Major Players of 20 mL
Table 20. Major Players of 50 mL
Table 21. Major Players of 100 mL
Table 22. Global Propofol and Ciprofol Injections Sales by Packaging (2021-2026) & (K Units)
Table 23. Global Propofol and Ciprofol Injections Sales Market Share by Packaging (2021-2026)
Table 24. Global Propofol and Ciprofol Injections Revenue by Packaging (2021-2026) & ($ million)
Table 25. Global Propofol and Ciprofol Injections Revenue Market Share by Packaging (2021-2026)
Table 26. Global Propofol and Ciprofol Injections Sale Price by Packaging (2021-2026) & (US$/Unit)
Table 27. Global Propofol and Ciprofol Injections Sale by Application (2021-2026) & (K Units)
Table 28. Global Propofol and Ciprofol Injections Sale Market Share by Application (2021-2026)
Table 29. Global Propofol and Ciprofol Injections Revenue by Application (2021-2026) & ($ million)
Table 30. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021-2026)
Table 31. Global Propofol and Ciprofol Injections Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Propofol and Ciprofol Injections Sales by Company (2021-2026) & (K Units)
Table 33. Global Propofol and Ciprofol Injections Sales Market Share by Company (2021-2026)
Table 34. Global Propofol and Ciprofol Injections Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Propofol and Ciprofol Injections Revenue Market Share by Company (2021-2026)
Table 36. Global Propofol and Ciprofol Injections Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Propofol and Ciprofol Injections Producing Area Distribution and Sales Area
Table 38. Players Propofol and Ciprofol Injections Products Offered
Table 39. Propofol and Ciprofol Injections Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Propofol and Ciprofol Injections Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Propofol and Ciprofol Injections Sales Market Share Geographic Region (2021-2026)
Table 44. Global Propofol and Ciprofol Injections Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Propofol and Ciprofol Injections Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Propofol and Ciprofol Injections Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Propofol and Ciprofol Injections Sales Market Share by Country/Region (2021-2026)
Table 48. Global Propofol and Ciprofol Injections Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Propofol and Ciprofol Injections Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Propofol and Ciprofol Injections Sales by Country (2021-2026) & (K Units)
Table 51. Americas Propofol and Ciprofol Injections Sales Market Share by Country (2021-2026)
Table 52. Americas Propofol and Ciprofol Injections Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Propofol and Ciprofol Injections Sales by Type (2021-2026) & (K Units)
Table 54. Americas Propofol and Ciprofol Injections Sales by Application (2021-2026) & (K Units)
Table 55. APAC Propofol and Ciprofol Injections Sales by Region (2021-2026) & (K Units)
Table 56. APAC Propofol and Ciprofol Injections Sales Market Share by Region (2021-2026)
Table 57. APAC Propofol and Ciprofol Injections Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Propofol and Ciprofol Injections Sales by Type (2021-2026) & (K Units)
Table 59. APAC Propofol and Ciprofol Injections Sales by Application (2021-2026) & (K Units)
Table 60. Europe Propofol and Ciprofol Injections Sales by Country (2021-2026) & (K Units)
Table 61. Europe Propofol and Ciprofol Injections Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Propofol and Ciprofol Injections Sales by Type (2021-2026) & (K Units)
Table 63. Europe Propofol and Ciprofol Injections Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Propofol and Ciprofol Injections Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Propofol and Ciprofol Injections Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Propofol and Ciprofol Injections Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Propofol and Ciprofol Injections Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Propofol and Ciprofol Injections
Table 69. Key Market Challenges & Risks of Propofol and Ciprofol Injections
Table 70. Key Industry Trends of Propofol and Ciprofol Injections
Table 71. Propofol and Ciprofol Injections Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Propofol and Ciprofol Injections Distributors List
Table 74. Propofol and Ciprofol Injections Customer List
Table 75. Global Propofol and Ciprofol Injections Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Propofol and Ciprofol Injections Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Propofol and Ciprofol Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Propofol and Ciprofol Injections Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Propofol and Ciprofol Injections Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Propofol and Ciprofol Injections Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Propofol and Ciprofol Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Propofol and Ciprofol Injections Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Propofol and Ciprofol Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Propofol and Ciprofol Injections Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Propofol and Ciprofol Injections Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Propofol and Ciprofol Injections Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Propofol and Ciprofol Injections Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Propofol and Ciprofol Injections Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Fresenius Kabi Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 90. Fresenius Kabi Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 91. Fresenius Kabi Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Fresenius Kabi Main Business
Table 93. Fresenius Kabi Latest Developments
Table 94. Pfizer Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 96. Pfizer Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. B. Braun Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 100. B. Braun Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 101. B. Braun Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. B. Braun Main Business
Table 103. B. Braun Latest Developments
Table 104. Sagent Pharmaceuticals Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 105. Sagent Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 106. Sagent Pharmaceuticals Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Sagent Pharmaceuticals Main Business
Table 108. Sagent Pharmaceuticals Latest Developments
Table 109. Dr. Reddy's Laboratories Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 110. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 111. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Dr. Reddy's Laboratories Main Business
Table 113. Dr. Reddy's Laboratories Latest Developments
Table 114. Rusoma Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 115. Rusoma Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 116. Rusoma Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Rusoma Main Business
Table 118. Rusoma Latest Developments
Table 119. Centurion Healthcare Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 120. Centurion Healthcare Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 121. Centurion Healthcare Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Centurion Healthcare Main Business
Table 123. Centurion Healthcare Latest Developments
Table 124. Wellona Pharma Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 125. Wellona Pharma Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 126. Wellona Pharma Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Wellona Pharma Main Business
Table 128. Wellona Pharma Latest Developments
Table 129. Hikma Pharmaceuticals Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 130. Hikma Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 131. Hikma Pharmaceuticals Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Hikma Pharmaceuticals Main Business
Table 133. Hikma Pharmaceuticals Latest Developments
Table 134. Avet Pharmaceuticals Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 135. Avet Pharmaceuticals Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 136. Avet Pharmaceuticals Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Avet Pharmaceuticals Main Business
Table 138. Avet Pharmaceuticals Latest Developments
Table 139. Xi?an Libang Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 140. Xi?an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 141. Xi?an Libang Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Xi?an Libang Pharmaceutical Main Business
Table 143. Xi?an Libang Pharmaceutical Latest Developments
Table 144. Guangdong Jiabo Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 145. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 146. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Guangdong Jiabo Pharmaceutical Main Business
Table 148. Guangdong Jiabo Pharmaceutical Latest Developments
Table 149. Sichuan Biokin Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 150. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 151. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Sichuan Biokin Pharmaceutical Main Business
Table 153. Sichuan Biokin Pharmaceutical Latest Developments
Table 154. Sichuan Kelun Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 155. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 156. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Sichuan Kelun Pharmaceutical Main Business
Table 158. Sichuan Kelun Pharmaceutical Latest Developments
Table 159. Jiangsu Nhwa Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 160. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 161. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Jiangsu Nhwa Pharmaceutical Main Business
Table 163. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 164. Jiangsu Yingke Biopharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 165. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 166. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Jiangsu Yingke Biopharmaceutical Main Business
Table 168. Jiangsu Yingke Biopharmaceutical Latest Developments
Table 169. Haisco Pharmaceutical Group Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 170. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 171. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Haisco Pharmaceutical Group Main Business
Table 173. Haisco Pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Propofol and Ciprofol Injections
Figure 2. Propofol and Ciprofol Injections Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Propofol and Ciprofol Injections Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Propofol and Ciprofol Injections Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Propofol and Ciprofol Injections Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Propofol and Ciprofol Injections Sales Market Share by Country/Region (2025)
Figure 10. Propofol and Ciprofol Injections Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Propofol Injections
Figure 12. Product Picture of Ciprofol Injections
Figure 13. Global Propofol and Ciprofol Injections Sales Market Share by Type in 2026
Figure 14. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of 1%
Figure 16. Product Picture of 2%
Figure 17. Product Picture of Other
Figure 18. Global Propofol and Ciprofol Injections Sales Market Share by Concentration in 2026
Figure 19. Global Propofol and Ciprofol Injections Revenue Market Share by Concentration (2021-2026)
Figure 20. Product Picture of 10 mL
Figure 21. Product Picture of 20 mL
Figure 22. Product Picture of 50 mL
Figure 23. Product Picture of 100 mL
Figure 24. Global Propofol and Ciprofol Injections Sales Market Share by Packaging in 2026
Figure 25. Global Propofol and Ciprofol Injections Revenue Market Share by Packaging (2021-2026)
Figure 26. Propofol and Ciprofol Injections Consumed in General Anesthesia
Figure 27. Global Propofol and Ciprofol Injections Market: General Anesthesia (2021-2026) & (K Units)
Figure 28. Propofol and Ciprofol Injections Consumed in Medical Procedures Sedation
Figure 29. Global Propofol and Ciprofol Injections Market: Medical Procedures Sedation (2021-2026) & (K Units)
Figure 30. Propofol and Ciprofol Injections Consumed in Mechanical Ventilation
Figure 31. Global Propofol and Ciprofol Injections Market: Mechanical Ventilation (2021-2026) & (K Units)
Figure 32. Propofol and Ciprofol Injections Consumed in Other
Figure 33. Global Propofol and Ciprofol Injections Market: Other (2021-2026) & (K Units)
Figure 34. Global Propofol and Ciprofol Injections Sale Market Share by Application (2025)
Figure 35. Global Propofol and Ciprofol Injections Revenue Market Share by Application in 2026
Figure 36. Propofol and Ciprofol Injections Sales by Company in 2026 (K Units)
Figure 37. Global Propofol and Ciprofol Injections Sales Market Share by Company in 2026
Figure 38. Propofol and Ciprofol Injections Revenue by Company in 2026 ($ millions)
Figure 39. Global Propofol and Ciprofol Injections Revenue Market Share by Company in 2026
Figure 40. Global Propofol and Ciprofol Injections Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Propofol and Ciprofol Injections Revenue Market Share by Geographic Region in 2026
Figure 42. Americas Propofol and Ciprofol Injections Sales 2021-2026 (K Units)
Figure 43. Americas Propofol and Ciprofol Injections Revenue 2021-2026 ($ millions)
Figure 44. APAC Propofol and Ciprofol Injections Sales 2021-2026 (K Units)
Figure 45. APAC Propofol and Ciprofol Injections Revenue 2021-2026 ($ millions)
Figure 46. Europe Propofol and Ciprofol Injections Sales 2021-2026 (K Units)
Figure 47. Europe Propofol and Ciprofol Injections Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Propofol and Ciprofol Injections Sales 2021-2026 (K Units)
Figure 49. Middle East & Africa Propofol and Ciprofol Injections Revenue 2021-2026 ($ millions)
Figure 50. Americas Propofol and Ciprofol Injections Sales Market Share by Country in 2026
Figure 51. Americas Propofol and Ciprofol Injections Revenue Market Share by Country (2021-2026)
Figure 52. Americas Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
Figure 53. Americas Propofol and Ciprofol Injections Sales Market Share by Application (2021-2026)
Figure 54. United States Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Propofol and Ciprofol Injections Sales Market Share by Region in 2026
Figure 59. APAC Propofol and Ciprofol Injections Revenue Market Share by Region (2021-2026)
Figure 60. APAC Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
Figure 61. APAC Propofol and Ciprofol Injections Sales Market Share by Application (2021-2026)
Figure 62. China Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 66. India Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Propofol and Ciprofol Injections Sales Market Share by Country in 2026
Figure 70. Europe Propofol and Ciprofol Injections Revenue Market Share by Country (2021-2026)
Figure 71. Europe Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
Figure 72. Europe Propofol and Ciprofol Injections Sales Market Share by Application (2021-2026)
Figure 73. Germany Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 74. France Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Propofol and Ciprofol Injections Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Propofol and Ciprofol Injections Sales Market Share by Application (2021-2026)
Figure 81. Egypt Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Propofol and Ciprofol Injections in 2026
Figure 87. Manufacturing Process Analysis of Propofol and Ciprofol Injections
Figure 88. Industry Chain Structure of Propofol and Ciprofol Injections
Figure 89. Channels of Distribution
Figure 90. Global Propofol and Ciprofol Injections Sales Market Forecast by Region (2027-2032)
Figure 91. Global Propofol and Ciprofol Injections Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Propofol and Ciprofol Injections Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Propofol and Ciprofol Injections Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Propofol and Ciprofol Injections Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Propofol and Ciprofol Injections Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Propofol and Ciprofol Injections
Figure 2. Propofol and Ciprofol Injections Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Propofol and Ciprofol Injections Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Propofol and Ciprofol Injections Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Propofol and Ciprofol Injections Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Propofol and Ciprofol Injections Sales Market Share by Country/Region (2025)
Figure 10. Propofol and Ciprofol Injections Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Propofol Injections
Figure 12. Product Picture of Ciprofol Injections
Figure 13. Global Propofol and Ciprofol Injections Sales Market Share by Type in 2026
Figure 14. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of 1%
Figure 16. Product Picture of 2%
Figure 17. Product Picture of Other
Figure 18. Global Propofol and Ciprofol Injections Sales Market Share by Concentration in 2026
Figure 19. Global Propofol and Ciprofol Injections Revenue Market Share by Concentration (2021-2026)
Figure 20. Product Picture of 10 mL
Figure 21. Product Picture of 20 mL
Figure 22. Product Picture of 50 mL
Figure 23. Product Picture of 100 mL
Figure 24. Global Propofol and Ciprofol Injections Sales Market Share by Packaging in 2026
Figure 25. Global Propofol and Ciprofol Injections Revenue Market Share by Packaging (2021-2026)
Figure 26. Propofol and Ciprofol Injections Consumed in General Anesthesia
Figure 27. Global Propofol and Ciprofol Injections Market: General Anesthesia (2021-2026) & (K Units)
Figure 28. Propofol and Ciprofol Injections Consumed in Medical Procedures Sedation
Figure 29. Global Propofol and Ciprofol Injections Market: Medical Procedures Sedation (2021-2026) & (K Units)
Figure 30. Propofol and Ciprofol Injections Consumed in Mechanical Ventilation
Figure 31. Global Propofol and Ciprofol Injections Market: Mechanical Ventilation (2021-2026) & (K Units)
Figure 32. Propofol and Ciprofol Injections Consumed in Other
Figure 33. Global Propofol and Ciprofol Injections Market: Other (2021-2026) & (K Units)
Figure 34. Global Propofol and Ciprofol Injections Sale Market Share by Application (2025)
Figure 35. Global Propofol and Ciprofol Injections Revenue Market Share by Application in 2026
Figure 36. Propofol and Ciprofol Injections Sales by Company in 2026 (K Units)
Figure 37. Global Propofol and Ciprofol Injections Sales Market Share by Company in 2026
Figure 38. Propofol and Ciprofol Injections Revenue by Company in 2026 ($ millions)
Figure 39. Global Propofol and Ciprofol Injections Revenue Market Share by Company in 2026
Figure 40. Global Propofol and Ciprofol Injections Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Propofol and Ciprofol Injections Revenue Market Share by Geographic Region in 2026
Figure 42. Americas Propofol and Ciprofol Injections Sales 2021-2026 (K Units)
Figure 43. Americas Propofol and Ciprofol Injections Revenue 2021-2026 ($ millions)
Figure 44. APAC Propofol and Ciprofol Injections Sales 2021-2026 (K Units)
Figure 45. APAC Propofol and Ciprofol Injections Revenue 2021-2026 ($ millions)
Figure 46. Europe Propofol and Ciprofol Injections Sales 2021-2026 (K Units)
Figure 47. Europe Propofol and Ciprofol Injections Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Propofol and Ciprofol Injections Sales 2021-2026 (K Units)
Figure 49. Middle East & Africa Propofol and Ciprofol Injections Revenue 2021-2026 ($ millions)
Figure 50. Americas Propofol and Ciprofol Injections Sales Market Share by Country in 2026
Figure 51. Americas Propofol and Ciprofol Injections Revenue Market Share by Country (2021-2026)
Figure 52. Americas Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
Figure 53. Americas Propofol and Ciprofol Injections Sales Market Share by Application (2021-2026)
Figure 54. United States Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Propofol and Ciprofol Injections Sales Market Share by Region in 2026
Figure 59. APAC Propofol and Ciprofol Injections Revenue Market Share by Region (2021-2026)
Figure 60. APAC Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
Figure 61. APAC Propofol and Ciprofol Injections Sales Market Share by Application (2021-2026)
Figure 62. China Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 66. India Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Propofol and Ciprofol Injections Sales Market Share by Country in 2026
Figure 70. Europe Propofol and Ciprofol Injections Revenue Market Share by Country (2021-2026)
Figure 71. Europe Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
Figure 72. Europe Propofol and Ciprofol Injections Sales Market Share by Application (2021-2026)
Figure 73. Germany Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 74. France Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Propofol and Ciprofol Injections Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Propofol and Ciprofol Injections Sales Market Share by Application (2021-2026)
Figure 81. Egypt Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Propofol and Ciprofol Injections Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Propofol and Ciprofol Injections in 2026
Figure 87. Manufacturing Process Analysis of Propofol and Ciprofol Injections
Figure 88. Industry Chain Structure of Propofol and Ciprofol Injections
Figure 89. Channels of Distribution
Figure 90. Global Propofol and Ciprofol Injections Sales Market Forecast by Region (2027-2032)
Figure 91. Global Propofol and Ciprofol Injections Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Propofol and Ciprofol Injections Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Propofol and Ciprofol Injections Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Propofol and Ciprofol Injections Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Propofol and Ciprofol Injections Revenue Market Share Forecast by Application (2027-2032)
